ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Intellectual property and issues in China and potential impact on US entities
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Taxation/Internal Revenue Code TAX
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
| BRADLEY ALLEN ROSSIN | — |
| BELA SASTRY | — |
Copyright/Patent/Trademark CPT
HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
Health Issues HCR
Issues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing programIssues related to pediatric medication access and impact of public guidelines on access Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number) Issues related to oncology legislation, including medication affordability Issues related to opiod use, diversion and DEA scheduling (no legislation) Issues related to transition of care from different care sites (no legislation) Issues related to drug safety and supply chain protections, including e-labeling (no bill number)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA FIRVIDA | — |
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
| BELA SASTRY | — |
Medicare/Medicaid MMM
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid program awareness, including discussions on potential changes to program strucutre Issues related to transition of care from different care sites (no legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA FIRVIDA | — |
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
| BELA SASTRY | — |
Consumer Issues/Safety/Products CSP
Issues related to drug safety and supply chain protections, including e-labeling (no bill number)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.